What is the drug of choice for anxiety in a 70‑year‑old patient undergoing chemotherapy?

Lorazepam is the drug of choice for anxiety in a 70-year-old patient undergoing chemotherapy

For elderly patients receiving chemotherapy who require anti-anxiety medication, lorazepam 1 mg orally as needed is the recommended first-line agent, with important caveats about duration and monitoring. 1

Rationale and Evidence Base

Primary Recommendation: Lorazepam

• Lorazepam is specifically included in Mayo Clinic antiemetic guidelines for chemotherapy patients at a dose of 1 mg orally every 1-2 hours as needed, with the caveat not to give if the patient has excessive drowsiness 1
• The NCCN Distress Management guidelines (Category 1 recommendation) support psychotherapy with or without an anxiolytic for anxiety treatment after eliminating medical causes 1
• For anticipatory nausea and vomiting (which is anxiety-related), lorazepam 1 mg orally at bedtime the night before chemotherapy and 1 mg the morning of chemotherapy is specifically recommended 1

Critical Safety Considerations in the Elderly

Benzodiazepines carry significant risks in elderly patients that must be carefully weighed:

• Increased risk of falls is a major concern, particularly in frail or elderly patients 1
• Cognitive impairment is a documented adverse effect that can be particularly problematic in this age group 1
• Risk of abuse and dependence necessitates time-limited use in accordance with psychiatric guidelines 1
• Use lower doses (0.25-0.5 mg) in older or frail patients, especially if co-administered with antipsychotics 1
• May paradoxically cause delirium, drowsiness, and agitation 1

Alternative and Adjunctive Approaches

SSRIs as First-Line for Sustained Anxiety:

• If anxiety is moderate to severe or persistent beyond acute chemotherapy-related distress, SSRIs (selective serotonin reuptake inhibitors) are preferred over benzodiazepines for longer-term management 1, 2
• Fluoxetine has demonstrated efficacy in randomized controlled trials for improving depressive and anxiety symptoms in adult cancer patients 1
• SSRIs have more favorable safety profiles in the elderly compared to benzodiazepines, though cytochrome P450 interactions must be considered 2

Buspirone as an Alternative:

• Buspirone may have benefit but lacks robust studies specifically in elderly populations 2
• It does not carry the same risks of dependence, falls, or cognitive impairment as benzodiazepines 2

Medications to Avoid:

• Tricyclic antidepressants (TCAs) and MAOIs are not recommended in elderly patients due to suboptimal side effect and safety profiles 2
• Beta-blockers should generally be avoided when treating anxiety in the elderly 2
• Antipsychotics carry a black box warning for increased mortality in elderly patients with dementia and lack sufficient evidence for routine anxiety treatment 2

Clinical Algorithm for Decision-Making

Step 1: Assess the Nature and Timing of Anxiety

• If anxiety is anticipatory or procedure-related (pre-chemotherapy, pre-procedure): Use lorazepam 1 mg orally as needed 1
• If anxiety is persistent or generalized: Consider SSRI therapy rather than chronic benzodiazepine use 1, 2

Step 2: Evaluate Patient-Specific Risk Factors

• History of falls: Use lower lorazepam doses (0.25-0.5 mg) or avoid benzodiazepines entirely 1
• Cognitive impairment or dementia: Strongly consider alternatives to benzodiazepines 1, 2
• Concurrent opioid use: Exercise extreme caution due to risk of oversedation and respiratory depression 1
• COPD or respiratory insufficiency: Use lower doses or avoid benzodiazepines 1

Step 3: Implement Non-Pharmacologic Interventions

• Psychotherapy should be offered concurrently with or without anxiolytic medication (NCCN Category 1 recommendation) 1
• Behavioral modification and biofeedback techniques may be helpful for anticipatory anxiety 1

Step 4: Monitor and Reassess

• Assess compliance, symptom relief, and adverse effects monthly or until symptoms subside 1
• After 8 weeks of treatment, if symptom reduction is poor despite good compliance, alter the treatment course (add psychological intervention, change medication, or refer to individual psychotherapy) 1
• Consider tapering from benzodiazepines if symptoms are controlled and primary environmental sources of anxiety are no longer present; longer tapering periods are necessary with benzodiazepines 1

Common Pitfalls to Avoid

• Do not prescribe benzodiazepines for long-term use without clear justification and regular reassessment 1, 2
• Do not overlook medical causes of anxiety such as uncontrolled pain, metabolic disturbances, medication effects (bronchodilators), or opioid withdrawal 1
• Do not fail to screen for depression, as anxiety and depression frequently co-occur in cancer patients, and suicide risk is twice that of the general population in this group 1
• Do not combine benzodiazepines with high-dose olanzapine due to reports of fatalities 1
• Do not assume all anxiety requires medication; mild anxiety may be managed with usual supportive care by the primary oncology team 1

Practical Prescribing Details

Lorazepam Dosing for Elderly Chemotherapy Patients:

• Starting dose: 0.5-1 mg orally as needed 1
• Frequency: Every 1-2 hours as needed (maximum 2 mg per dose) 1
• Routes: Can be given orally, sublingually, subcutaneously, or intravenously 1
• Dose reduction: Use 0.25-0.5 mg in frail elderly or those with COPD 1